Insulin tresiba generic?

Short answer: no. There isn’t a generic (or FDA-approved biosimilar) version of Tresiba (insulin degludec) available in the United States as of 2024.

Notes:
- Tresiba is a long-acting basal insulin (insulin degludec), a biologic product. Generics for biologics aren’t common, and as of 2024 there was no approved biosimilar for degludec in the US.
- In other countries there may be biosimilars or alternative products, but approval status varies by country.

If cost or access is the goal, you could discuss with your clinician about:
- Other basal insulins with biosimilars available in the US (e.g., insulin glargine products like Basaglar or Semglee) depending on your plan.
- Patient assistance programs or discounts from the manufacturer.
- Possible switching options and dosing adjustments (only under medical supervision).

Want me to tailor options based on your country and insurance type?